Metraipolis › archive › dc_c56ad3192be2

A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced cutaneous melanoma — Europe PMC PMID:41701511

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41701511
DOI
10.1002/cncr.70326
License (as archived)
solo-consultazione
Archived
2026-11-06T09:08:09.924Z
SHA-256 of the archived text
0294cc0aecb18c91cdab7921002599d9e97118ba37a14f550a29afd8beb60b31
Stable URL of this page
https://metraipolis.com/documento/dc_c56ad3192be2

How to cite

A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced cutaneous melanoma — Europe PMC PMID:41701511 — Europe PMC (en), https://europepmc.org/article/MED/41701511 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c56ad3192be2 (Metraipolis archive dc_c56ad3192be2, sha256 0294cc0aecb18c91cdab7921002599d9e97118ba37a14f550a29afd8beb60b31)
BibTeX
@misc{dcc56ad3192be2,
  title = {A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced cutaneous melanoma — Europe PMC PMID:41701511},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41701511},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c56ad3192be2; sha256 0294cc0aecb18c91cdab7921002599d9e97118ba37a14f550a29afd8beb60b31},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41701511. Agents can read the archived copy with the MCP tool read_document.